Embolic Stroke Clinical Trials

13 recruitingLast updated: May 13, 2026

There are 13 actively recruiting embolic stroke clinical trials across 9 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Seoul, South Korea, Bern, Switzerland, Basel, Switzerland. Updated daily from ClinicalTrials.gov.


Embolic Stroke Trials at a Glance

13 actively recruiting trials for embolic stroke are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in Seoul, Bern, and Basel. Lead sponsors running embolic stroke studies include Insel Gruppe AG, University Hospital Bern, Asan Medical Center, and Acandis GmbH.

Browse embolic stroke trials by phase

Treatments under study

About Embolic Stroke Clinical Trials

Looking for clinical trials for Embolic Stroke? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Embolic Stroke trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Embolic Stroke clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Translational Immunodiagnostics in Stroke (TrImS)

Atrial FibrillationAcute Ischemic StrokeCardioembolic Stroke+9 more
The University of Hong Kong650 enrolled1 locationNCT05300997
Recruiting

SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation

ElderlyIschemic StrokeEmbolic Stroke of Undetermined Source+1 more
Taichung Veterans General Hospital400 enrolled3 locationsNCT07479147
Recruiting

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

Carotid artery stentingEmbolic Stroke of Undetermined SourceCarotid Artery Disease+3 more
Acandis GmbH536 enrolled1 locationNCT07166731
Recruiting
Not Applicable

Atrial Fibrillation Detection Using MEMO Patch in Patients With Stroke of Unknown Cause

Embolic Stroke of Undetermined Source
Asan Medical Center100 enrolled1 locationNCT07295769
Recruiting

AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM

Embolic Stroke of Undetermined Source
Inha University Hospital92 enrolled5 locationsNCT07347691
Recruiting

Left Atrial Strain and Cryptogenic Stroke

Embolic Stroke of Undetermined SourceIschemic Stroke, CryptogenicIschemic Stroke, Embolic+2 more
University of Pittsburgh900 enrolled1 locationNCT07224178
Recruiting

Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation

Brain DiseasesCentral Nervous System DiseasesAtrial Fibrillation+11 more
Insel Gruppe AG, University Hospital Bern500 enrolled1 locationNCT06954610
Recruiting

Detecting Cardiac Thrombi in Acute Ischemic Stroke on Cardiac CT Versus Transoesophageal Echocardiography

Ischemic StrokeCardioembolic StrokeLeft Atrial Appendage Thrombosis+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)39 enrolled1 locationNCT06585228
Recruiting

Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Ischemic StrokeOccult CancerCancer-related Stroke+3 more
Insel Gruppe AG, University Hospital Bern370 enrolled3 locationsNCT06100718
Recruiting
Phase 2Phase 3

EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
University of East Anglia100 enrolled1 locationNCT06715449
Recruiting

Echocardiographic Predictors of Atrial Fibrillation

Atrial FibrillationStroke, IschemicEmbolic Stroke of Undetermined Source+1 more
Karl Landsteiner University of Health Sciences200 enrolled1 locationNCT05044208
Recruiting

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

Non Valvular Atrial FibrillationEmbolic Stroke
Lifetech Scientific (Shenzhen) Co., Ltd.579 enrolled5 locationsNCT04559243
Recruiting

Prospective Registry of Elderly ESUS With PFO

Embolic Stroke of Undetermined Source
Asan Medical Center1,200 enrolled1 locationNCT05238610